Procter A M, Phillips J A, Cooper D N
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Hum Genet. 1998 Sep;103(3):255-72. doi: 10.1007/s004390050815.
Although most cases of short stature associated with growth hormone (GH) deficiency are sporadic and idiopathic, some 5-30% have an affected first degree relative consistent with a genetic aetiology for the condition. Several different types of mutational lesion in the pituitary-expressed growth hormone (GH1) gene have been described in affected individuals. This review focuses primarily on the GH1 mutational spectrum and its unusual features, discusses potential mechanisms of mutagenesis and pathogenesis, and examines the correlation between mutant genotype and clinical phenotype. The characterization of pathological lesions in several other pituitary-expressed genes that are epistatic to GH1 (POU1F1, PROP1 and GHRHR) has identified additional causes of GH deficiency, the molecular genetics of which are also explored.
虽然大多数与生长激素(GH)缺乏相关的身材矮小病例是散发性和特发性的,但约5%-30%的患者有患病的一级亲属,这与该病的遗传病因相符。在受影响的个体中,已描述了垂体表达的生长激素(GH1)基因的几种不同类型的突变损伤。本综述主要关注GH1突变谱及其异常特征,讨论诱变和发病机制的潜在机制,并研究突变基因型与临床表型之间的相关性。对GH1上位性的其他几个垂体表达基因(POU1F1、PROP1和GHRHR)中的病理损伤进行表征,已确定了GH缺乏的其他原因,同时也探讨了其分子遗传学。